European Cancer Screening and Early Detection Policy Summit

Conference Details

Date: 17 February 2026

Time: 14:30

Duration: 2 days

Location: Brussels, Belgium and Online

Cost: Register online for more information.

Organiser: European Cancer Organisation

Conference Website

Conference Description

Newly Implementable Programmes for Prostate, Lung and Gastric Cancer Screening

Three years ago, the European Union reshaped the agenda on cancer screening. The goal? Save lives through early detection, with a focus on prostate, lung, and gastric cancer.

How? Launch a series of projects – PRAISE-U, SOLACE, and TOGAS – to pilot and prepare for the implementation of new screening programmes which account for the needs of individuals and their different backgrounds. Now it's time to assess the progress and turn pilots into programmes.

This is a unique event for the cancer community. Make sure to be part of it.

17 & 18 February - Brussels & online.
Registrations are open now!

The European Cancer Screening and Early Detection Policy Summit will showcase three implementation-focused projects under the EU4Health Programme 2021-2027:

• PRAISE-U: testing a personalised, cost-effective prostate cancer screening strategy through risk-based diagnostic algorithms;
• SOLACE: designing comprehensive guidelines for lung cancer screening using low-dose computed tomography;
• TOGAS: developing and implementing gastric cancer prevention strategies tailored for communities across Europe.

The European Cancer Screening and Early Detection Policy Summit will be chaired by Stella Kyriakides, Former European Commissioner for Health and Food Safety and David Collingridge, Editor-in-Chief, The Lancet Oncology. 

The two-day programme will gather health experts, patients, and policymakers to

• Explain the results of PRAISE-U, SOLACE and TOGAS, share key findings and define effective implementation of these three screening programmes;
• Exchange views among screening and early detection communities and pave the way for future exploration and international initiatives;
• Expand policy action through ambitious recommendations, ensuring screening and early detection’s place on the political agenda.